U
ANGO icon

UBS’s AngioDynamics ANGO Stock Holding History

UBS’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Buy
+400
New +$5.71K ﹤0.01% 9420
2014
Q1 		– Sell
-17,200
Closed -$295K – 10396
2013
Q4 		$295K Buy
+17,200
New +$265K ﹤0.01% 4871

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS's ANGO Position: Q3 2014 in Review

UBS reduced its AngioDynamics (ANGO) stake by 26% in Q3 2014, selling an estimated $10.5K and leaving 2,157 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #7461.

UBS first reported a position in ANGO in Q2 2013 and has held it in 5 quarters since. The position peaked at $47K in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.

  • UBS held 2,157 shares of AngioDynamics worth $30K as of Q3 2014.
  • UBS sold 739 AngioDynamics shares in Q3 2014, an estimated $10.5K.
  • AngioDynamics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7461 holding.
  • UBS first reported a position in AngioDynamics in Q2 2013 and has held it in 5 quarters since.
  • UBS's AngioDynamics position peaked at $47K in Q2 2014.
  • 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.